These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

98 related articles for article (PubMed ID: 7532137)

  • 1. Hepatitis C viraemia and antibody to core epitopes in anti-HCV ELISA negative blood donors.
    Ferroni P; Gasparini V; Zaninetti M; Colzani D; Mascolo G
    Eur J Epidemiol; 1994 Oct; 10(5):649-50. PubMed ID: 7532137
    [No Abstract]   [Full Text] [Related]  

  • 2. Anti-GOR without anti-HCV core is not associated with hepatitis C viremia.
    Bååth L; Widell A
    Vox Sang; 1994; 66(2):151. PubMed ID: 7514327
    [No Abstract]   [Full Text] [Related]  

  • 3. A sensitive serodiagnosis of hepatitis C virus (HCV) infection with two non-fused peptides: comparison of antibody responses detected with a newly developed assay and a commercial second-generation test.
    Sato A; Ida N; Ishikawa M; Tanahashi K; Nakamura H; Sho Y; Arima T; Kunitomo T
    Microbiol Immunol; 1993; 37(4):295-304. PubMed ID: 7688847
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Hepatitis C virus infection in children with hemophilia: characterization of antibody response to four different antigens and relationship of antibody response, viremia, and hepatic dysfunction.
    Kanesaki T; Kinoshita S; Tsujino G; Yoshioka K; Ikegami N
    J Pediatr; 1993 Sep; 123(3):381-7. PubMed ID: 7689096
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Diagnosis of hepatitis C virus (HCV) infection using an immunodominant chimeric polyprotein to capture circulating antibodies: reevaluation of the role of HCV in liver disease.
    Chien DY; Choo QL; Tabrizi A; Kuo C; McFarland J; Berger K; Lee C; Shuster JR; Nguyen T; Moyer DL
    Proc Natl Acad Sci U S A; 1992 Nov; 89(21):10011-5. PubMed ID: 1279666
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Sensitivity of an anti-HCV core peptide ELISA.
    Bresters D; Reesink HW; Cuypers HT; Jansen PL; Mauser-Bunschoten EP; van der Poel CL; Lelie PN
    J Med Virol; 1992 Jul; 37(3):187-91. PubMed ID: 1279109
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Identification of four epitopes in hepatitis C virus core protein.
    Ferroni P; Mascolo G; Zaninetti M; Colzani D; Pregliasco F; Pirisi M; Barbone F; Gasparini V
    J Clin Microbiol; 1993 Jun; 31(6):1586-91. PubMed ID: 7686184
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Patterns of immune responses to the host-encoded GOR and hepatitis C virus core-derived epitopes with relation to hepatitis C viremia, genotypes, and liver disease severity.
    Quiroga JA; Pardo M; Navas S; Martín J; Carreño V
    J Infect Dis; 1996 Feb; 173(2):300-5. PubMed ID: 8568289
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Second-generation hepatitis C Elisa antibody tests confirmed by the four-antigen recombinant immunoblot assay correlate well with hepatitis C viremia and chronic liver disease in Swedish blood donors.
    Shev S; Foberg U; Fryden A; Hermodsson S; Lindh G; Lindholm A; Månsson AS; von Sydow M; Weiland O; Widell A
    Vox Sang; 1993; 65(1):32-7. PubMed ID: 7689776
    [TBL] [Abstract][Full Text] [Related]  

  • 10. IgM antibody to a hepatitis C virus core peptide (CP14) for monitoring activity of liver disease in patients with acute or chronic hepatitis C.
    Nagayama R; Miyake K; Tsuda F; Okamoto H
    J Med Virol; 1994 Mar; 42(3):311-7. PubMed ID: 7516423
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Enhanced sensitivity of a second generation ELISA for antibody to hepatitis C virus.
    Bresters D; Cuypers HT; Reesink HW; Schaasberg WP; van der Poel CL; Mauser-Bunschoten EP; Houghton M; Choo QL; Kuo G; Lesniewski R
    Vox Sang; 1992; 62(4):213-7. PubMed ID: 1379394
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Evaluation of antibody against AR142, a synthetic peptide derived from the core sequence of hepatitis C virus, in the diagnosis of non-A, non-B chronic liver disease.
    Du L; Shimomura H; Nakagawa H; Hasui T; Tsuji H; Wato M; Kondo J; Ukida M; Yamada G; Tsuji T
    Intern Med; 1993 Nov; 32(11):843-8. PubMed ID: 7516745
    [TBL] [Abstract][Full Text] [Related]  

  • 13. ELISA for anti-HCV antibody employing a shorter synthetic core region peptide.
    Nakagiri I; Ichihara K
    J Virol Methods; 1995 Mar; 52(1-2):195-207. PubMed ID: 7539443
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Enzyme-linked immunosorbent assay for antibodies against core protein of hepatitis C virus with a synthetic oligopeptide].
    Sugiyasu T
    Fukuoka Igaku Zasshi; 1993 Apr; 84(4):148-58. PubMed ID: 7686127
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Quantitative antibody responses to structural (Core) and nonstructural (NS3, NS4, and NS5) hepatitis C virus proteins among seroconverting injecting drug users: impact of epitope variation and relationship to detection of HCV RNA in blood.
    Beld M; Penning M; van Putten M; Lukashov V; van den Hoek A; McMorrow M; Goudsmit J
    Hepatology; 1999 Apr; 29(4):1288-98. PubMed ID: 10094977
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Predictive value of screening tests for persistent hepatitis C virus infection evidenced by viraemia. Japanese experience.
    Watanabe J; Matsumoto C; Fujimura K; Shimada T; Yoshizawa H; Okamoto H; Iizuka H; Tango T; Ikeda H; Endo N
    Vox Sang; 1993; 65(3):199-203. PubMed ID: 7504373
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Performance of an enzyme-linked immunosorbent assay system for antibodies to hepatitis C virus with two new antigens (c11/c7).
    Saito M; Hasegawa A; Kashiwakuma T; Kohara M; Sugi M; Miki K; Yamamoto T; Mori H; Ohta Y; Tanaka E
    Clin Chem; 1992 Dec; 38(12):2434-9. PubMed ID: 1281050
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Markers of hepatitis C virus infection in Sardinian blood donors: relationship with alanine aminotransferase levels.
    Lai ME; Mazzoleni AP; Farci P; Melis A; Porru A; Orgiana G; Arnone M; Balestrieri A
    J Med Virol; 1993 Dec; 41(4):282-8. PubMed ID: 7508972
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Follow-up of hepatitis C virus infection in chimpanzees: determination of viraemia and specific humoral immune response.
    Hilfenhaus J; Krupka U; Nowak T; Cummins LB; Fuchs K; Roggendorf M
    J Gen Virol; 1992 Apr; 73 ( Pt 4)():1015-9. PubMed ID: 1378877
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Clinical usefulness of an assay for hepatitis C virus core in the diagnosis of non-A, non-B hepatitis and monitoring of the response to interferon therapy.
    Kawano S; Tanaka M; Fujiyama S; Sato S; Taura Y; Goto M; Chikazawa H; Sato T
    J Gastroenterol Hepatol; 1994; 9(3):217-22. PubMed ID: 7519894
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.